In Figures S8 and S9, utilizing four different GBM transcriptome databases, it is shown that CYP27A1 and ACOX2 enzymes are overexpressed in GBM, and that overexpression is linked to poor patient outcomes (data taken directly from Gliovis). This evidence concerns the gene CYP27A1 and glioblastoma.